Colistin Resistance Onset Strategies and Genomic Mosaicism in Clinical Acinetobacter baumannii Lineages

被引:3
|
作者
Cafiso, Viviana [1 ]
Stracquadanio, Stefano [1 ]
Dovere, Veronica [2 ]
Lo Verde, Flavia [1 ]
Zega, Alessandra [1 ]
Pigola, Giuseppe [1 ]
Barnini, Simona [3 ]
Ghelardi, Emilia [2 ]
Stefani, Stefania [1 ]
机构
[1] Univ Catania, Dept Biomed & Biotechnol Sci, I-95123 Catania, Italy
[2] Univ Pisa, Azienda Osped Univ Pisana, Dept Translat Res & New Technol Med & Surg, I-56126 Pisa, Italy
[3] Azienda Osped Univ Pisana, Bacteriol Unit, I-56126 Pisa, Italy
来源
PATHOGENS | 2021年 / 10卷 / 11期
关键词
A; baumannii; colistin resistance stability; genomic mosaicism; phylogenetic lineages; DAPTOMYCIN NONSUSCEPTIBILITY; HETERORESISTANCE; MECHANISMS; VIRULENCE;
D O I
10.3390/pathogens10111516
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The treatment of multidrug-resistant Gram-negative infections is based on colistin. As result, COL-resistance (COL-R) can develop and spread. In Acinetobacter baumannii, a crucial step is to understand COL-R onset and stability, still far to be elucidated. COL-R phenotypic stability, onset modalities, and phylogenomics were investigated in a clinical A. baumannii sample showing a COL resistant (COL(R)) phenotype at first isolation. COL-R was confirmed by Minimum-Inhibitory-Concentrations as well as investigated by Resistance-Induction assays and Population-Analysis-Profiles (PAPs) to determine: (i) stability; (ii) inducibility; (iii) heteroresistance. Genomics was performed by Mi-Seq Whole-Genome-Sequencing, Phylogenesis, and Genomic Epidemiology by bioinformatics. COL(R) A. baumannii were subdivided as follows: (i) 3 A. baumannii with stable and high COL MICs defining the "homogeneous-resistant " onset phenotype; (ii) 6 A. baumannii with variable and lower COL MICs displaying a "COL-inducible " onset phenotype responsible for adaptive-resistance or a "subpopulation " onset phenotype responsible for COL-heteroresistance. COL-R stability and onset strategies were not uniquely linked to the amount of LPS and cell envelope charge. Phylogenomics categorized 3 lineages clustering stable and/or unstable COL-R phenotypes with increasing genomic complexity. Likewise, different nsSNP profiling in genes already associated with COL-R marked the stable and/or unstable COL-R phenotypes. Our investigation finds out that A. baumannii can range through unstable or stable COL(R) phenotypes emerging via different "onset strategies " within phylogenetic lineages displaying increasing genomic mosaicism.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Investigation of Colistin Resistance and Heteroresistance in Acinetobacter spp. Isolates from Various Clinical Specimens
    Kuzucu, Esra Akkan
    Caliskan, Elif
    Ocal, Duygu
    Dansuk, Zeynep
    Cagatay, Mustafa
    Erdem, Gul
    Tekeli, Alper
    MEDITERRANEAN JOURNAL OF INFECTION MICROBES AND ANTIMICROBIALS, 2020, 11
  • [32] Colistin Resistance in Acinetobacter baumannii MDR-ZJ06 Revealed by a Multiomics Approach
    Hua, Xiaoting
    Liu, Lilin
    Fang, Youhong
    Shi, Qiucheng
    Li, Xi
    Chen, Qiong
    Shi, Keren
    Jiang, Yan
    Zhou, Hua
    Yu, Yunsong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
  • [33] The Resistance of Pseudomonas aeruginosa and Acinetobacter baumannii to Colistin in a Public Hospital in Alkharj, Saudi Arabia
    Ahmed, Nehad J.
    LATIN AMERICAN JOURNAL OF PHARMACY, 2021, 40 (01): : 201 - 205
  • [34] Contribution of different mechanisms to aminoglycoside resistance in clinical isolates of Acinetobacter baumannii
    Saleh, Neveen M.
    Saad, Sarah I.
    El-Sayed, Mohamed
    El-Sayyad, Gharieb S.
    Safe, Feriala A. Abo
    MICROBIAL PATHOGENESIS, 2023, 182
  • [35] Comparative genomic analysis of Acinetobacter baumannii clinical isolates reveals extensive genomic variation and diverse antibiotic resistance determinants
    Liu, Fei
    Zhu, Yuying
    Yi, Yong
    Lu, Na
    Zhu, Baoli
    Hu, Yongfei
    BMC GENOMICS, 2014, 15
  • [36] The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It
    Scoffone, Viola Camilla
    Trespidi, Gabriele
    Barbieri, Giulia
    Arshad, Arooba
    Israyilova, Aygun
    Buroni, Silvia
    ANTIBIOTICS-BASEL, 2025, 14 (01):
  • [37] Antimicrobial Resistance in Acinetobacter baumannii: A Challenge to Clinical Settings
    Sharma, Shilpa
    Kaur, Amandeep
    Bajaj, Renuka
    Singh, Kanwardeep
    Sharma, Sarika
    Sharma, Sandeep
    MOLECULAR GENETICS MICROBIOLOGY AND VIROLOGY, 2024, 39 (03) : 219 - 236
  • [38] Acquisition of Colistin Resistance Links Cell Membrane Thickness Alteration with a Point Mutation in the lpxD Gene in Acinetobacter baumannii
    Saleh, Neveen M.
    Hesham, Marwa S.
    Amin, Magdy A.
    Mohamed, Reham Samir
    ANTIBIOTICS-BASEL, 2020, 9 (04):
  • [39] Synergy between Colistin and the Signal Peptidase Inhibitor MD3 Is Dependent on the Mechanism of Colistin Resistance in Acinetobacter baumannii
    Martinez-Guitan, Marta
    Vazquez-Ucha, Juan C.
    Odingo, Joshua
    Parish, Tanya
    Poza, Margarita
    Waite, Richard D.
    Bou, German
    Wareham, David W.
    Beceiro, Alejandro
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) : 4375 - 4379
  • [40] Colistin and Polymyxin B Dosage Regimens against Acinetobacter baumannii: Differences in Activity and the Emergence of Resistance
    Cheah, Soon-Ee
    Li, Jian
    Tsuji, Brian T.
    Forrest, Alan
    Bulitta, Juergen B.
    Nation, Roger L.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (07) : 3921 - 3933